|
ZNF525 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.04139999535758E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.03390000000003E-05 |
| Normal-vs-Stage2 |
5.5259999998114E-07 |
| Normal-vs-Stage3 |
1.40569999973472E-07 |
| Normal-vs-Stage4 |
4.79539999997947E-06 |
| Stage1-vs-Stage2 |
4.264400E-02 |
| Stage1-vs-Stage3 |
7.500200E-02 |
| Stage1-vs-Stage4 |
1.874810E-01 |
| Stage2-vs-Stage3 |
7.523200E-01 |
| Stage2-vs-Stage4 |
7.509000E-01 |
| Stage3-vs-Stage4 |
9.812600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.89859999949671E-07 |
| Normal-vs-AfricanAmerican |
2.19980000004671E-06 |
| Normal-vs-Asian |
1.358400E-01 |
| Caucasian-vs-AfricanAmerican |
3.760200E-02 |
| Caucasian-vs-Asian |
7.259900E-03 |
| AfricanAmerican-vs-Asian |
1.139690E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.41579999999253E-05 |
| Normal-vs-Female |
5.38129999450021E-08 |
| Male-vs-Female |
1.700030E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.764300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.05770000535799E-08 |
| Normal-vs-Age(61-80Yrs) |
1.15960000046655E-07 |
| Normal-vs-Age(81-100Yrs) |
2.446300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.022300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.129800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.166600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.397400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.785800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.182600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.239800E-02 |
| Classical-VS-Follicular |
3.837800E-04 |
| Classical-VS-Other |
9.503000E-01 |
| Classical-VS-Normal |
2.27629999999257E-05 |
| Tall-VS-Follicular |
6.362400E-01 |
| Tall-VS-Other |
5.876600E-01 |
| Tall-VS-Normal |
6.41249999999705E-05 |
| Follicular-VS-Other |
3.179800E-01 |
| Follicular-VS-Normal |
2.68519999568895E-08 |
| Other-VS-Normal |
1.358980E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.12209999958424E-07 |
| Normal-vs-N1 |
5.9492999999966E-05 |
| N0-vs-N1 |
8.991200E-01 |
|
|
